Published: 2017-02-24

Protective effect of Picrorhiza kurroa on Alzheimer’s disease induced by aluminium chloride in rats

Somasekhar K. Reddy, Sudheer A., Arunamma M., Likitha Sree P., Jyothirmayi E.


Background: Alzheimer’s disease is a progressive neurodegenerative disorder characterized by cognitive deterioration together with declining activities of daily living and behavioural changes. The present work is aimed to investigate the effect of methanolic extract of rhizomes of Picrorhiza kurroa against aluminum chloride induced Alzheimer’s disease.

Methods: Wistar rats were selected in this study and were divided into 5 groups (6 each). Group I served as normal control. Group II received aluminum chloride (300mg/kg, P.O.). Group III and IV received ethanolic extract of Picrorhiza kurroa (200mg/kg, 400mg/kg, P.O. respectively) and inducing agent (AlCl3 300mg/kg, P.O.). Group V received rivastigmine (0.3mg/kg, I.P.) and inducing agent (AlCl3 300mg/kg, P.O.). The rats were given respective treatment for 20 days and behavioural parameters were determined on 20th day. After 20th day rats were sacrificed and anti-oxidant parameters, brain acetylcholinesterase content were determined.

Results: Oral administration of ethanolic extract of Picrorhiza kurroa at doses 200, 400mg/kg body weight showed improve in behavioural parameters when compared to AlCl3 induced rats, showed increase in superoxide dismutase, catalase, reduced glutathione and decreased levels of malondialdehyde and showed decrease in brain acetylcholinesterase content when compared to AlCl3 induced rats.

Conclusions: The study clearly demonstrated the beneficial effects of Picrorhiza kurroa by improving biochemical and behavioural parameters.


Alzheimer’s disease, Alcl3, Antioxidant parameters, Behavioural parameters, Picrorhiza kurroa

Full Text:



Alwakeel AI, Ali AA, Ahmed HI, Abu Elfotuh K, Khalil MG. Comparative study on the influence of epigallocatechin-3-gallate and/or coenzyme Q10 against Alzheimer’s disease induced by aluminium in normally-fed and protein malnourished rats. J Alzheimer’s Dis Parkinsonism. 2016; 6(3):1-10.

Al Mamun A, Wahid F, Sahab Uddin M, Iqbal MA, Rahman MM. Neurodefensive effect of Olea europaea L. in alloxan-induced cognitive dysfunction and brain tissue oxidative stress in mice: incredible natural nootropic. J Neurol Neurosci. 2016;7:1-9.

Bhattacharya B, Mangilal T, Nagakishore R. Alzheimer’s disease-pathophysiology, diagnosis and modern approach of treatment. World J Pharm Pharm Sci. 2014;3(10):1452-60.

Wattanathorn J, Uabundit N, Ingkaninan K, Mucimapura S. Cognitive enhancement and neuroprotective effects of Bacopa monnieri in Alzheimer’s disease model. J Ethno Pharmacol. 2010;127:26-31.

Eidi A, Sarkaki A, Mortazavi P, Hajipour S, Farbood Y, Valizadeh Z. Effect of gallic acid on dementia type of alzheimer disease in rats: electrophysiological and histological studies. Basic Clin Neurosci. 2016;7(2):97-106.

Manan A, Malik A, Rasool M, Qureshi MS, Pushparaj PN, Asif M, et al. Recent updates in the treatment of neurodegenerative disorders using natural compounds. eCAM. 2014;2014:1-7.

Mahdy KA, Gouda NAM, Marrie AEH, Yassin NAZ, EI-Shenawy SMA, Farrag ARH, Ibrahim BMM. Protective effect of ginger (zingiber officinale) on Alzheimer's disease induced in rats. J Neuroinfect Dis. 2014;5(2):2-10.

Rao RV, Descamps O, Varghese J, Bredesen DE. Ayurvedic medicinal plants for Alzheimer’s disease: a review. Alzheimers Res Ther. 2012;4(22):2-9.

Kimura R, Ohno M. Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model. Neurobiol Dis. 2009;33:229-35.

Beheshti S, Aghaie R. Therapeutic effect of frankincense in a rat model of Alzheimer’s disease. Avicenna J Phytomed. 2016;6(4):468-75.

Devi KP, Syad AN. Botanics a potential source of new therapies for Alzheimer’s disease. Botanics: Targets and Therapy. 2014;4:11-26.

Kuboyama T, Tohda C, Komatsu K. Effects of Ashwagandha (roots of Withania somnifera) on neurodegenerative diseases. Biol Pharm Bull. 2014;37(6):892-7.

Somesh T, Mahadevan N, Nanjan MJ. Analysis of picroside i and kutkoside in picrorhiza kurroa and its formulation by HPTLC. Int J Res Pharm Biomed Sci. 2012;3(1):25-30.

Katoch M, Fazli IS, Suri KA, Ahuja A, Qazi GN. Effect of altitude on picroside content in core collections of Picrorhiza kurroa from the north western Himalayas. J Nat Med. 2011;65:578-82.

Bhandari P, Kumar N, Singh B, Kaul VK. Simultaneous determination of sugar and picrosides in Picrorhiza species using ultrasonic extraction and high performance liquid chromatography with evaporative light scattering detection. J Chromatography A. 2008;1194:257-61.

Rajkumar V, Guha G, Kumar RA. Antioxidant and antineoplastic activities of Picrorhiza kurroa extract. Food Chem Toxicol. 2011;49:363-9.

Kulkarni S. 1999. Experiment no. 4.4: to study CNS depressant property of chlorpromazine on locomotor activity of mice using actophotometer. Handbook of Experimental Pharmacology. 117-119.

Vijitruth R, Liu M, Choi DY. Cyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson's disease. J Neuroinflamm. 2006;3:6.

Suba V, Murugesan T, Rao RB, Pal M, Mandal SC, Saha BP. Neuropharmacological profile of Barleria lupulina Lindl. extract in animal models. J Ethnopharmacol. 2002;81:251-5.

Reddy DS, Kulkarni SK. Possible Role of nitric oxide in the nootropic and antiamnesic effects of neurosteroids on aging- and dizocilpine-induced learning impairment. Brain Res. 1998;799:215-29.

Vorhees CV, Williams MT. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc. 2006;1:848-58.

Jing H, Yan MC, Jian HW, Yuan YM. Effect of coadministration of morphine and cholinergic antagonists on Y maze spatial recognition memory retrieval and locomotor activity in mice. Zoological Res. 2008;29:613-20.

Makni M, Sefi M, Fetoui H, Garoui MEI, Gargouri N, Boudawara T, Zeghal N. Flax and pumpkin seeds mixture ameliorates diabetic nephropathy in rats. Food Chemical Toxicol. 2010;48:2407-12.

Ghanemi A. Alzheimer’s disease therapies: Selected advances and future perspectives. Alexandria J Med. 2015;51(1):1-3.

Sargazi M, Shenkin A, Roberts NB. Aluminium-induced injury to kidney proximal tubular cells: Effects on markers of oxidative damage. J Trace Elem Med Biol. 2006;19:267-73.

Krishnan S, Cairns R, Howard R. Cannabinoids for the treatment of dementia. The Cochrane database of systematic reviews. 2009;2:CD007204.

Abascal K, Yarnell E. Alzheimer’s disease. Part 2- A botanical treatment plan. Alternative and Complementary Therapies. 2004;10:67-72.

Perry EK, Pickering AT, Wang WW, Houghton PJ, Perry NS. Medicinal plants and Alzheimer’s disease: from ethnobotany to phytotherapy. J Pharm Pharmacol. 1999;5:527-34.

Howes M.J, Perry NS, Houghton PJ. Plants with traditional uses and activities, relevant to the management of Alzheimer’s disease and other cognitive disorders. Phytother Res. 2003;17:1-18.

Kennedy DO, Wightman EL. Herbal extracts and phytochemicals: plant secondary metabolites and the enhancement of human brain function. Adv Nutr. 2011;2:32-50.

Kumar V. Potential medicinal plants for CNS disorders: an overview. Phytother Res. 2006;20:1023-35.